Physical stabilisation of amorphous ketoconazole in solid dispersions with polyvinylpyrrolidone K25.
about
Investigating the Dissolution Performance of Amorphous Solid Dispersions Using Magnetic Resonance Imaging and Proton NMR.Influence of formulation and processing variables on properties of itraconazole nanoparticles made by advanced evaporative precipitation into aqueous solution.Preparation and in vitro evaluation of hydrophilic fenretinide nanoparticles.Preparation and Characterization of Solid Dispersions of Artemether by Freeze-Dried Method.Review: physical chemistry of solid dispersions.Differential scanning calorimetry techniques: applications in biology and nanoscienceInteractions between drugs and polymers influencing hot melt extrusion.Thermal Processing of PVP- and HPMC-Based Amorphous Solid Dispersions.The role of the carrier in the formulation of pharmaceutical solid dispersions. Part II: amorphous carriers.Methods to characterize the structure of food powders - a review.Griseofulvin/carrier blends: application of partial least squares (PLS) regression analysis for estimating the factors affecting the dissolution efficiency.Multivariate Quantification of the Solid State Phase Composition of Co-Amorphous Naproxen-Indomethacin.Thermodynamic scaling of molecular dynamics in supercooled liquid state of pharmaceuticals: Itraconazole and ketoconazole.Optimization of pellets containing solid dispersion prepared by extrusion/spheronization using central composite design and desirability functionImproved dissolution of oleanolic acid with ternary solid dispersions.Physicochemical investigations and stability studies of amorphous gliclazide.Moringa coagulant as a stabilizer for amorphous solids: Part IFormulation and optimization of mouth dissolve tablets containing rofecoxib solid dispersion.Preparation and characterization of etoricoxib solid dispersions using lipid carriers by spray drying technique.Initial Drug Dissolution from Amorphous Solid Dispersions Controlled by Polymer Dissolution and Drug-Polymer Interaction.Wetting Kinetics: an Alternative Approach Towards Understanding the Enhanced Dissolution Rate for Amorphous Solid Dispersion of a Poorly Soluble Drug.Physicochemical characterization and drug-release properties of celecoxib hot-melt extruded glass solutions.Enthalpy relaxation studies of two structurally related amorphous drugs and their binary dispersions.Preparation and characterization of solid dispersion of simvastatin.Perphenazine solid dispersions for orally fast-disintegrating tablets: physical stability and formulation.Dissolution rate and stability study of flavanone aglycones, naringenin and hesperetin, by drug delivery systems based on polyvinylpyrrolidone (PVP) nanodispersions.Physical stability of micronized powders produced by spray-freezing into liquid (SFL) to enhance the dissolution of an insoluble drug.Prediction of acetaminophen's solubility in poly(ethylene oxide) at room temperature using the Flory-Huggins theory.Cefuroxime axetil solid dispersion with polyglycolized glycerides for improved stability and bioavailability.Curcumin amorphous solid dispersions: the influence of intra and intermolecular bonding on physical stability.Miscibility behavior and formation mechanism of stabilized felodipine-polyvinylpyrrolidone amorphous solid dispersions.Influence of different polymers on crystallization tendency and dissolution behavior of cilnidipine in solid dispersions.In vitro release--in vivo microbiological and toxicological studies on ketoconazole lipid granules.Cefuroxime axetil solid dispersions prepared using solution enhanced dispersion by supercritical fluids.SLN and NLC for topical delivery of ketoconazole.Preparation and Characterization of Cabamazepine Cocrystal in Polymer Solution.A formulation comparison between micro- and nanosuspensions: the importance of particle size for absorption of a model compound, following repeated oral administration to rats during early development.Development and Validation of Stability-Indicating Method for the Simultaneous Determination of Ketoconazole and Beauvericin in Pharmaceutical Tablets.Hot melt extrusion versus spray drying: hot melt extrusion degrades albendazole.Phase behavior, intermolecular interaction, and solid state characterization of amorphous solid dispersion of Febuxostat.
P2860
Q30993966-55C0CFC9-8519-47C2-99EB-8ACE63503061Q34323630-C90FCDE3-C706-4CBE-A549-A914AA3FD3FBQ35137881-F6CCF95F-0908-41BB-AE3B-2C886FD12441Q35667814-F6712A11-E2CA-48B0-B119-82D53F479E9AQ37643840-F3D2E7AF-F212-47F9-A57A-806D5F197622Q37814131-087F30C6-694A-4561-B03D-FFE2BC5C8CDEQ38170190-0711AA87-F0DA-44E9-8348-8AFC6E81F96EQ38619443-248FEDB8-0DB5-44D0-905D-F4601F776D3CQ38856754-DE7544D8-3FA1-44D3-8BD1-3F032092E8C2Q39080112-CD6DCE8B-FCC9-4675-9A90-4BFF264A562AQ39423564-05AFA25F-C814-4832-A7B1-E29BE2F80BC9Q40375864-C8E8809B-9B5E-4FCE-A9C1-A7FF2896E2FBQ40838625-3720CB4E-6124-4E59-9269-2BB6C175ABADQ41650065-5AB095E8-5217-4C75-95DD-A9B45BB9C2B1Q41916465-A1C88C70-ECA6-4583-BCF7-63E028EA2E2BQ41988346-EEA7795E-5BE7-4021-89E1-602045D3D9E2Q41988358-1F2F838E-D9F8-4725-AC5B-8A04C272E838Q41990098-5596340D-7DE7-4DEA-B524-32E0D0197A00Q41990256-C50163D6-4954-4787-808B-972E45710C31Q42104195-79F0ABE1-B7E6-4360-A194-97A497722C70Q42646407-DA345B57-B07A-4946-9C2E-9783D88FD897Q42820297-100E2E9B-7904-467D-8167-C148F8835BCFQ42918134-4A5ABE83-E79C-435F-9A55-E3FEB405A188Q43025612-D09DED49-A4AF-4520-A743-6C23CE65054BQ43232050-10E0677A-5F80-4619-979F-D2FC441FA7A2Q43296465-7389E769-C0B5-42D5-B438-3BD66A264C1FQ44449451-64643450-69F4-4C18-B03F-DDDC99CEA499Q45943466-31AA7C17-85DC-47EE-8C16-B066DD83F032Q45978265-124CC3BA-CE04-4F47-891A-9368A1545143Q46411919-99DE31B0-40E7-465E-9D1D-7935C9AD226AQ46658143-F417E588-AAC1-4649-B931-30853172A15AQ46776168-C15AE50E-1EB9-4CD3-AF0B-8396D47FDFBBQ46831439-EA4A6DD4-8B26-40B2-82D0-F5D2F6C35BC2Q46851055-0D131D03-72B0-4E1D-A35C-644712024FEFQ46856307-1E11FA08-C10F-4E36-BE68-5302424A02A7Q47294973-FEC9CCE7-ECD8-4954-9E4D-8821AFE037DEQ47422612-3D2D17D3-404E-41A7-9FD6-C4ED1435EC8BQ48930232-8F3AA1A8-22ED-400D-94BA-E3C71ACE0A29Q50280294-8EC36AE0-51FA-43DE-8CB3-E43100F17946Q50717873-4B284C80-BF80-4DB0-BF39-F5D1DD0AF410
P2860
Physical stabilisation of amorphous ketoconazole in solid dispersions with polyvinylpyrrolidone K25.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Physical stabilisation of amor ...... with polyvinylpyrrolidone K25.
@ast
Physical stabilisation of amor ...... with polyvinylpyrrolidone K25.
@en
type
label
Physical stabilisation of amor ...... with polyvinylpyrrolidone K25.
@ast
Physical stabilisation of amor ...... with polyvinylpyrrolidone K25.
@en
prefLabel
Physical stabilisation of amor ...... with polyvinylpyrrolidone K25.
@ast
Physical stabilisation of amor ...... with polyvinylpyrrolidone K25.
@en
P2093
P1476
Physical stabilisation of amor ...... with polyvinylpyrrolidone K25
@en
P2093
P304
P356
10.1016/S0928-0987(00)00173-1
P407
P577
2001-01-01T00:00:00Z